Prevalence of CCR7‐Positive CD8 T Cells as a Prognostic Factor in B‐Cell Maturation Antigen ‐Targeted Chimeric Antigen Receptor T Cell Therapy
In the future, our results will help us to select specific patients that are likely to have a more favorable outcome and should contribute to establishing an optimal application strategy for CAR-T cell therapies in RRMM.
Authors
- Tomoyuki Nakamura
- Masaki Ri (ORCID: https://orcid.org/0000-0002-9617-486X)
- Takahiro Nakashima (ORCID: https://orcid.org/0000-0001-6369-6154)
- Tomotaka Suzuki (ORCID: https://orcid.org/0000-0001-5694-8501)
- Toru Ebina (ORCID: https://orcid.org/0009-0000-4341-9563)
- Takaomi Sanda (ORCID: https://orcid.org/0000-0003-1621-4954)
- Yoshiaki Marumo (ORCID: https://orcid.org/0009-0003-6326-4994)
- Shiori Kinoshita (ORCID: https://orcid.org/0009-0008-1645-2200)
- Yoshiko Oshima
- Shinsuke Iida (ORCID: https://orcid.org/0000-0002-4951-960X)
- Hirokazu Komatsu (ORCID: https://orcid.org/0000-0003-1627-3743)
- Tomoko Narita
Institutions
- Nagoya City University (JP)
Publication Details
- Journal
- eJHaem
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1002/jha2.70040
- Citations
- 1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Nagoya City University